Judgment of the Court (First Chamber); 6 December 2012. AstraZeneca AB and AstraZeneca plc v European Commission. Appeal — Competition — Abuse of dominant position — Market in anti-ulcer medicines — Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products — Misleading representations — Deregistration of marketing authorisations — Obstacles to the marketing of generic medicinal products and to parallel imports.